According to a press release an investigation on behalf of investors of Anesiva, Inc. (NASDAQ: ANSV) over possible breaches of fiduciary duty by certain directors and/or officers of Anesiva, Inc. (NASDAQ: ANSV) was announced.

According to the press release the investigation by a law firm focuses on whether certain directors and/or officers of Anesiva, Inc caused Anesiva, Inc. to enter into improper change of control agreements with certain investors which effectively prohibit the its Board of Directors from fulfilling their fiduciary duties to explore all opportunities to maximize shareholder value. Anesiva, Inc. (Anesiva) is a biopharmaceutical company focused on the development and commercialization of therapeutic treatments for pain management.